Small World: Delistings, contract wins, a maiden dividend and a new addition to AIM
Barely a month seems to go by without another small cap company announcing its intention to delist from the London stock market. The latest escapee is leading cell therapeutics firm MaxCyte (MXCT:AIM) which announced its intention to cancel its AIM listing on 15 April. The proposed cancellation, if approved by shareholders, is expected to take place on 25 June. The board of directors believe...